Related Experiment Video
Updated: Aug 2, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Immunotherapy of asthma
1TB and Lung Diseases Res-Institute, Warszana, Poland.
Allergie Et Immunologie
|October 1, 1991
Summary
Immunotherapy (IT) for allergies remains controversial, with varying acceptance and side effect risks globally. Patient compliance and specific treatment schedules are crucial for successful allergy immunotherapy outcomes.
Area of Science:
- Allergy and Immunology
- Clinical Medicine
- Public Health
Background:
- Immunotherapy (IT) for allergies has a history of acceptance for environmental allergens like pollen and house dust.
- Historically, there has been less consensus regarding IT for food, drug, and acute bacterial allergies.
- Renewed controversy surrounds immunotherapy, particularly concerning its safety and efficacy across different regions.
Purpose of the Study:
- To review the historical and current perspectives on immunotherapy for various allergic conditions.
- To examine the geographical variations in reported side effects and fatalities associated with immunotherapy.
- To identify factors influencing the efficacy and safety of immunotherapy, including patient demographics and treatment protocols.
Main Methods:
- A review of historical data and current controversies regarding immunotherapy.
- Analysis of reported side effects, including anaphylaxis, across different countries (France, Great Britain, USA).
- Evaluation of factors affecting immunotherapy outcomes, such as patient age, infection status, and injection schedules.
Main Results:
- Immunotherapy acceptance varied by allergen type in 1965, with ongoing debate.
- Significant geographical differences exist in immunotherapy-related adverse events, with higher risks noted in Great Britain and the USA compared to France.
- Treatment efficacy is clearest in adolescent patients, while chronic infections and poor patient compliance negatively impact outcomes.
Conclusions:
- Immunotherapy remains a subject of debate, influenced by allergen type and geographical location.
- Careful consideration of injection schedules and patient compliance is essential to optimize immunotherapy safety and effectiveness.
- Further research may be needed to standardize protocols and mitigate risks associated with allergy immunotherapy.
More Related Videos
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...